- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
BMY
The 7 Most Undervalued Value Stocks to Buy Now
Undervalued value stocks remain available even as investors have pivoted toward low-valuation stocks in a volatile year for markets.
Best Stocks 2022: Why Bristol-Myers Squibb (BMY) Stock Is a Clear Winner
There's a reason BMY stock is currently winning our Best Stocks for 2022 contest. Investors should buy BMY for value, safety and dividends.
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.
Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment
Sotyktu's Phase 3 study showed it more effective than Amgen's Otezla for treating psoriasis.
Best Stocks for 2022: Bristol-Myers Squibb Is Having a Great Year
BMY stock is up 21% this year. That's impressive compared to the market as a whole, which has entered bear territory, and it has room to grow.
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way.